These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
84 related items for PubMed ID: 7688581
1. Analysis of the site on a TNF-alpha molecule which affects type II TNF receptor binding in human cells. Ikegami H, Arai N, Moriyasu J, Taniguchi M, Tsusaki K, Honji N, Kohno K, Ando S, Kurimoto M. Lymphokine Cytokine Res; 1993 Jun; 12(3):173-80. PubMed ID: 7688581 [Abstract] [Full Text] [Related]
2. Epitope mapping and functional analysis of three murine IgG1 monoclonal antibodies to human tumor necrosis factor-alpha. Bloom JW, Bettencourt JD, Mitra G. J Immunol; 1993 Sep 01; 151(5):2707-16. PubMed ID: 7689613 [Abstract] [Full Text] [Related]
3. Involvement of an Asn/Val cleavage site in the production of a soluble form of a human tumor necrosis factor (TNF) receptor. Site-directed mutagenesis of a putative cleavage site in the p55 TNF receptor chain. Gullberg U, Lantz M, Lindvall L, Olsson I, Himmler A. Eur J Cell Biol; 1992 Aug 01; 58(2):307-12. PubMed ID: 1330568 [Abstract] [Full Text] [Related]
4. Human TNF mutants with selective activity on the p55 receptor. Van Ostade X, Vandenabeele P, Everaerdt B, Loetscher H, Gentz R, Brockhaus M, Lesslauer W, Tavernier J, Brouckaert P, Fiers W. Nature; 1993 Jan 21; 361(6409):266-9. PubMed ID: 8380906 [Abstract] [Full Text] [Related]
5. Identification of an epitope of tumor necrosis factor (TNF)-receptor type 1 (p55) recognized by a TNF-alpha-antagonist monoclonal antibody. Corti A, Bagnasco L, Cassani G. Lymphokine Cytokine Res; 1994 Jun 21; 13(3):183-90. PubMed ID: 7524695 [Abstract] [Full Text] [Related]
6. Biological activities of human tumor necrosis factor-alpha and its novel mutants. Xi T, Shi X, Guo D, Dong X, Xu X, Zhu D. Biochem Mol Biol Int; 1996 Apr 21; 38(4):855-62. PubMed ID: 8728116 [Abstract] [Full Text] [Related]
7. Interactions between novel tumor necrosis factor-alpha mutants and receptors on tumor and normal cells. Nakamura S, Masegi T, Fukuoka M, Kitai K, Kato A, Ichikawa Y, Watanabe N, Niitsu Y. Agric Biol Chem; 1991 Jan 21; 55(1):53-7. PubMed ID: 1369315 [Abstract] [Full Text] [Related]
12. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors. Kost ER, Mutch DG, Herzog TJ. Gynecol Oncol; 1999 Mar 21; 72(3):392-401. PubMed ID: 10053112 [Abstract] [Full Text] [Related]
15. Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant. Mukai Y, Shibata H, Nakamura T, Yoshioka Y, Abe Y, Nomura T, Taniai M, Ohta T, Ikemizu S, Nakagawa S, Tsunoda S, Kamada H, Yamagata Y, Tsutsumi Y. J Mol Biol; 2009 Jan 30; 385(4):1221-9. PubMed ID: 19084540 [Abstract] [Full Text] [Related]
16. A novel human scFv fragment against TNF-alpha from de novo design method. Chang H, Qin W, Li Y, Zhang J, Lin Z, Lv M, Sun Y, Feng J, Shen B. Mol Immunol; 2007 Jul 30; 44(15):3789-96. PubMed ID: 17485112 [Abstract] [Full Text] [Related]
17. Interaction of acetylcholinesterase with the G4 domain of the laminin alpha1-chain. Johnson G, Swart C, Moore SW. Biochem J; 2008 May 01; 411(3):507-14. PubMed ID: 18215127 [Abstract] [Full Text] [Related]
19. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels. Calderon TM, Factor SM, Hatcher VB, Berliner JA, Berman JW. Lab Invest; 1994 Jun 01; 70(6):836-49. PubMed ID: 8015288 [Abstract] [Full Text] [Related]